Pacific Edge's revenue climbs, US future still uncertain

Pacific Edge's revenue climbs, US future still uncertain
Very strong revenue growth, but profit still some distance away (Image: Pacific Edge)
Ella Somers
A boom in Pacific Edge’s Cxbladder test sales boosted the firm’s operating revenue soar by 71%, with a helping hand from favourable exchange rates.Chief executive Peter Meintjes said the 2023 financial year had been a year of “enormous change and achievement” for the cancer diagnostic company.“Pacific Edge is geared for growth,” he told the NZX.Operating revenue for the twelve months to March 31 rose $19.6 million, up from $11.4m in the previous year while total revenue jumped 88% to $26.1m.The revenue climb...

More Markets

Key says insider trading claim without merit
Markets

Key says insider trading claim without merit

US claimants target the company's directors over share prices and trading.

Staff reporters 20 May 2024
Positive Gentrack result gives sharemarket a boost
Markets Market close

Positive Gentrack result gives sharemarket a boost

The S&P/NZX 50 Index closed at 11,720.8, up 35.92 points or 0.31%.

Graham Skellern 20 May 2024
Comvita opens books to bidder, cuts costs
Markets

Comvita opens books to bidder, cuts costs

The honey firm is finding a further $10m in costs to cut as it also cuts back guidance.

The Warehouse forced back to basics
Markets

Rebecca Stevenson: The Warehouse forced back to basics

While its rivals were fighting for customers, The Warehouse obsessed about itself.